Therapeutic Solutions International Announces Appointment of Dr. Thomas E. Ichim to its Subsidiary Emvolio, Inc.
May 01, 2017 10:53 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 01, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the Board of Directors of its majority owned subsidiary, Emvolio, Inc....
Therapeutic Solutions International's Subsidiary OmniBiome, Inc. Announces First Oral Microbiome Therapy for Periodontal Disease
April 24, 2017 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - April 24, 2017) - Therapeutic Solutions International, Inc.'s (OTC PINK: TSOI) subsidiary, OmniBiome, Inc., announced today the successful development of an oral...
Therapeutic Solutions International's Subsidiary, Emvolio, Inc., Files Investigational New Drug Application for StemVacs Cancer Immunotherapy
April 12, 2017 09:45 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - April 12, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of an Investigational New Drug (IND) application by its...
Therapeutic Solutions International Announces Filing of new Immunotherapy Patent and Exclusive Patent License Agreement with Subsidiary Emvolio, Inc.
April 10, 2017 11:44 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - April 10, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a new patent and exclusive licensing agreement with majority...
Therapeutic Solutions Receives Allowance on Patent Claim from the US Patent Office Covering ProJuvenol(R) Active Ingredient Pterostilbene in Cancer Immunotherapies
February 06, 2017 08:30 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA --(Marketwired - February 06, 2017) - Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that the United States Patent and Trademark Office allowed issuance of...
Therapeutic Solutions International Reports Augmentation of Cancer Immunotherapy Using Pterostilbene
July 11, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - July 11, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) reported novel data supporting the use of pterostilbene, a natural analog of resveratrol...
Unique Alzheimer's Disease Vaccines Show Great Potential in Pre-Clinical Studies
July 05, 2016 16:12 ET
|
Capo Therapeutics, Inc.
OCEANSIDE, CA --(Marketwired - July 05, 2016) - Capo Therapeutics, Inc., announced today that researchers at The Institute of Molecular Medicine in Huntington Beach, CA, along with collaborators at...
Therapeutic Solutions International Announces New Liposomal Products
June 22, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - June 22, 2016) - Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today the addition of four new consumer products to our nutraceutical division. The...
Therapeutic Solutions International's Subsidiary MolecuVax, Inc. Announces Licensing of "Universal Cancer Vaccine" With Demonstrated Efficacy in Breast Cancer
May 09, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - May 09, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an exclusive license agreement between its subsidiary,...
Therapeutic Solutions International Files Patent Covering ProJuvenol(C) and Its Active Ingredient Pterostilbene
April 28, 2016 09:00 ET
|
Therapeutic Solutions International, Inc.
OCEANSIDE, CA--(Marketwired - April 28, 2016) - Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent application covering the use of ProJuvenol© and...